CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY - USD ($) $ in Thousands	Total	Common Stock	Additional Paid-In Capital	Treasury Stock	Accumulated Other Comprehensive Income	Accumulated Earnings (Deficit)
Beginning balance (in shares) at Dec. 31, 2020		93,379,508
Beginning balance at Dec. 31, 2020	$ 127,871	$ 9	$ 179,549		$ 93	$ (51,780)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock-based compensation	1,593		1,593
Unrealized gain (loss) on investment in convertible notes	469				469
Net income	1,501					1,501
Ending balance (in shares) at Mar. 31, 2021		93,379,508
Ending balance at Mar. 31, 2021	131,434	$ 9	181,142		562	(50,279)
Beginning balance (in shares) at Dec. 31, 2020		93,379,508
Beginning balance at Dec. 31, 2020	127,871	$ 9	179,549		93	(51,780)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Unrealized gain on interest rate caplets	0
Unrealized gain (loss) on investment in convertible notes	5,358
Net income	24,753
Ending balance (in shares) at Sep. 30, 2021		94,042,341
Ending balance at Sep. 30, 2021	164,144	$ 9	185,711		5,451	(27,027)
Beginning balance (in shares) at Mar. 31, 2021		93,379,508
Beginning balance at Mar. 31, 2021	131,434	$ 9	181,142		562	(50,279)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock-based compensation	2,148		2,148
Exercise of common stock options (in shares)		281,245
Exercise of common stock options	685		685
Unrealized gain (loss) on investment in convertible notes	5,204				5,204
Net income	12,445					12,445
Ending balance (in shares) at Jun. 30, 2021		93,660,753
Ending balance at Jun. 30, 2021	151,916	$ 9	183,975		5,766	(37,834)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock-based compensation	966		966
Exercise of common stock options (in shares)		381,588
Exercise of common stock options	770		770
Unrealized gain on interest rate caplets	0
Unrealized gain (loss) on investment in convertible notes	(315)				(315)
Net income	10,807					10,807
Ending balance (in shares) at Sep. 30, 2021		94,042,341
Ending balance at Sep. 30, 2021	164,144	$ 9	185,711		5,451	(27,027)
Beginning balance (in shares) at Dec. 31, 2021		93,410,563
Beginning balance at Dec. 31, 2021	158,461	$ 9	187,656	$ (8,983)	0	(20,221)
Beginning balance (in shares) at Dec. 31, 2021				(701,305)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Repurchase of common stock (in shares)		(1,087,990)		(1,087,990)
Repurchase of common stock	(13,934)			$ (13,934)
Stock-based compensation	1,605		1,605
Exercise of stock-based awards (in shares)		161,969
Exercise of stock-based awards	38		38
Unrealized gain on interest rate caplets	4,864				4,864
Net income	15,788					15,788
Ending balance (in shares) at Mar. 31, 2022		92,484,542
Ending balance at Mar. 31, 2022	166,822	$ 9	189,299	$ (22,917)	4,864	(4,433)
Ending balance (in shares) at Mar. 31, 2022				(1,789,295)
Beginning balance (in shares) at Dec. 31, 2021		93,410,563
Beginning balance at Dec. 31, 2021	$ 158,461	$ 9	187,656	$ (8,983)	0	(20,221)
Beginning balance (in shares) at Dec. 31, 2021				(701,305)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Repurchase of common stock (in shares)	(5,679,510)
Repurchase of common stock	$ (61,900)
Unrealized gain on interest rate caplets	12,696
Unrealized gain (loss) on investment in convertible notes	0
Net income	60,696
Ending balance (in shares) at Sep. 30, 2022		88,569,672
Ending balance at Sep. 30, 2022	180,882	$ 9	192,314	$ (64,612)	12,696	40,475
Ending balance (in shares) at Sep. 30, 2022				(5,865,193)
Beginning balance (in shares) at Mar. 31, 2022		92,484,542
Beginning balance at Mar. 31, 2022	166,822	$ 9	189,299	$ (22,917)	4,864	(4,433)
Beginning balance (in shares) at Mar. 31, 2022				(1,789,295)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Repurchase of common stock (in shares)		(2,326,413)		(2,326,413)
Repurchase of common stock	(25,498)			$ (25,498)
Stock-based compensation	2,281		2,281
Reissuance of treasury stock in business combination (in shares)		515,622		515,622
Reissuance of treasury stock in business combination	5,584		(705)	$ 6,289
Exercise of stock-based awards (in shares)		85,580
Exercise of stock-based awards	315		315
Unrealized gain on interest rate caplets	1,907				1,907
Net income	22,464					22,464
Ending balance (in shares) at Jun. 30, 2022		90,759,331
Ending balance at Jun. 30, 2022	173,875	$ 9	191,190	$ (42,126)	6,771	18,031
Ending balance (in shares) at Jun. 30, 2022				(3,600,086)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Repurchase of common stock (in shares)		(2,265,107)		(2,265,107)
Repurchase of common stock	(22,486)			$ (22,486)
Stock-based compensation	54		1,070
Exercise of stock-based awards (in shares)		75,448
Exercise of stock-based awards	1,070		54
Unrealized gain on interest rate caplets	5,925				5,925
Unrealized gain (loss) on investment in convertible notes	0
Net income	22,444					22,444
Ending balance (in shares) at Sep. 30, 2022		88,569,672
Ending balance at Sep. 30, 2022	$ 180,882	$ 9	$ 192,314	$ (64,612)	$ 12,696	$ 40,475
Ending balance (in shares) at Sep. 30, 2022				(5,865,193)